Loading...
TRUP logo

Trupanion, Inc.NasdaqGM:TRUP Rapport sur les actions

Capitalisation boursière US$985.4m
Prix de l'action
US$22.36
US$46.25
51.7% sous-évalué décote intrinsèque
1Y-50.8%
7D-12.6%
Valeur du portefeuille
Voir

Trupanion, Inc.

NasdaqGM:TRUP Rapport sur les actions

Capitalisation boursière : US$985.4m

Trupanion (TRUP) Aperçu de l'action

Trupanion Inc. et ses filiales proposent des assurances médicales pour chiens et chats sur la base d'un abonnement aux États-Unis, au Canada, en Europe continentale et en Australie. Plus de détails

TRUP analyse fondamentale
Score flocon de neige
Évaluation0/6
Croissance future1/6
Performances passées2/6
Santé financière4/6
Dividendes0/6

TRUP Community Fair Values

Create Narrative

See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.

Trupanion, Inc. Concurrents

Historique des prix et performances

Résumé des hausses, des baisses et des variations du cours de l'action pour la période du 1er janvier au 31 décembre 2009 Trupanion
Historique des cours de bourse
Prix actuel de l'actionUS$22.36
Plus haut sur 52 semainesUS$57.89
Plus bas sur 52 semainesUS$22.22
Bêta1.49
Variation sur 1 mois-14.85%
Variation sur 3 mois-20.03%
Variation sur 1 an-50.78%
Variation sur 3 ans3.42%
Variation sur 5 ans-71.54%
Évolution depuis l'introduction en bourse96.14%

Nouvelles et mises à jour récentes

Mise à jour du récit May 13

TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing

Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.
Mise à jour du récit Apr 22

TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns

Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.
Mise à jour du récit Apr 08

TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power

Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.

Recent updates

Mise à jour du récit May 13

TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing

Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.
Mise à jour du récit Apr 22

TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns

Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.
Mise à jour du récit Apr 08

TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power

Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.
Mise à jour du récit Mar 25

TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential

Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.
Mise à jour du récit Mar 10

TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing

Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.
Mise à jour du récit Feb 24

TRUP: Long Term Profitability Assumptions Will Support Future Upside Potential

Analysts have reduced their Trupanion price targets by approximately $10 to $46.25, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following recent research updates from multiple firms. Analyst Commentary Recent research updates on Trupanion point to a mix of optimism about the long term opportunity and caution about the execution and valuation risks in the near term.
Mise à jour du récit Feb 09

TRUP: Higher Future P/E Assumptions Will Support A Stronger Long-Term Repricing

Analysts have reduced their Trupanion price target by about $4 to US$63, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. Analyst Commentary Bullish analysts are refining their views on Trupanion as they revisit key valuation inputs such as fair value estimates, discount rates, revenue assumptions, profit margins and future P/E levels.
Mise à jour du récit Jan 25

TRUP: Revised P/E Assumptions Will Support Long Term Earnings Power

Analysts have reduced their price targets on Trupanion by $8, citing updated assumptions for revenue growth, profit margin and future P/E, which modestly adjust the risk and return profile they see for the stock. Analyst Commentary Bearish analysts cutting their price targets by $8 are signaling a more cautious stance on Trupanion, driven by updated assumptions for revenue growth, profit margin and future P/E.
Mise à jour du récit Jan 11

TRUP: Future Margin Gains And Share Discipline Will Support Long Term Earnings Power

Analysts are maintaining a US$42.00 price target for Trupanion, with small adjustments to revenue growth, profit margin assumptions and a lower future P/E helping to fine tune their outlook rather than reset it. What's in the News Trupanion reported that, between July 1 and September 30, 2025, it did not repurchase any shares under its existing program and has completed total buybacks of 95,021 shares for US$5.75 million, representing 0.23% of shares under the buyback announced on April 30, 2021 (company filing).
Mise à jour du récit Dec 27

TRUP: Future Margin Expansion Will Support Strengthening Long Term Earnings Power

Analysts have modestly maintained their price target on Trupanion at approximately $42.00, citing slightly stronger expectations for revenue growth, incremental profit margin improvement, and a marginally lower future price to earnings multiple that together support the current valuation stance. What's in the News Updated full year 2025 guidance now calls for total revenue of $1.433 billion to $1.439 billion and subscription revenue of $986 million to $989 million, implying roughly 15% year over year subscription growth at the midpoint (company guidance).
Mise à jour du récit Dec 12

TRUP: Future Margin Recovery Will Support Strengthening Long Term Earnings Power

Analysts have modestly reduced their price target on Trupanion from 45.00 dollars to 42.00 dollars. This reflects more conservative assumptions for revenue growth, profit margins, and valuation multiples, despite a largely unchanged risk outlook.
Mise à jour du récit Aug 10

Increasing Pet Ownership And Data Analytics Will Expand Market

The consensus price target for Trupanion has increased to $59.67 as analysts assign a higher future P/E multiple despite a modest decline in net profit margin, signaling greater optimism about its growth prospects. Valuation Changes Summary of Valuation Changes for Trupanion The Consensus Analyst Price Target has significantly risen from $53.00 to $59.67.
User avatar
Nouveau récit May 27

Global Expansion And Pricing Precision Will Shape Pet Markets

Enhanced pricing strategies, technology upgrades, and disciplined underwriting are driving margin expansion, higher operational efficiency, and more sustainable long-term earnings.
Article d’analyse May 13

Trupanion, Inc. (NASDAQ:TRUP) Looks Just Right With A 26% Price Jump

Trupanion, Inc. ( NASDAQ:TRUP ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...
Article d’analyse Feb 16

There's Reason For Concern Over Trupanion, Inc.'s (NASDAQ:TRUP) Price

When close to half the companies in the Insurance industry in the United States have price-to-sales ratios (or "P/S...
Seeking Alpha Dec 13

Trupanion: High Costs And Price Hikes Are Reasons To Avoid This Pet Insurer

Summary Trupanion's Q3'24 revenue grew 15% YoY to $327.5M, driven mainly by price hikes, but EPS missed estimates by $0.46. Subscription adjusted operating income surged 66% to $30.8M, improving margins, but new pet growth deceleration raises concerns. Expansion into Germany and Switzerland offers growth opportunities, but North American profitability and competitive pressures remain critical challenges. Trupanion faces risks from unsustainable price hikes, growing veterinary inflation, and higher acquisition costs. Its strategy of ramping up pet acquisition spending could pressure short-term profitability without guaranteeing long-term growth. Despite growth prospects in the pet insurance market, Trupanion’s high valuation, with an expected 7% revenue growth in 2025, makes it an expensive investment. Read the full article on Seeking Alpha
Article d’analyse Oct 25

Revenues Tell The Story For Trupanion, Inc. (NASDAQ:TRUP) As Its Stock Soars 25%

Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 25% gain in the last month alone...
Seeking Alpha Sep 24

Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade)

Summary Trupanion's stock surged over 60% since my June 2024 buy rating. Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive, indicating a sustainable business model. Price hikes are essential due to rising veterinary costs and increasing anxiety claims in pets, which could impact long-term profitability if not managed. Shares are no longer a buy, and I reiterate my $40 price target with a hold rating now. Read the full article on Seeking Alpha
Article d’analyse Aug 11

Trupanion, Inc. (NASDAQ:TRUP) Just Reported And Analysts Have Been Lifting Their Price Targets

It's been a pretty great week for Trupanion, Inc. ( NASDAQ:TRUP ) shareholders, with its shares surging 14% to US$38.30...
Article d’analyse Jul 31

A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb

Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 27% gain in the last month alone...
Seeking Alpha Jun 13

Trupanion: Growth First, Profitability Second

Summary Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later. Shares are a buy with a price target of $40. Read the full article on Seeking Alpha
Article d’analyse Feb 16

A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb

Despite an already strong run, Trupanion, Inc. ( NASDAQ:TRUP ) shares have been powering on, with a gain of 27% in the...
Seeking Alpha Feb 02

Trupanion: After All This Time, No Profits

Summary Pet insurance industry has seen significant growth due to the rising trend of millennials and Gen Z preferring pets over having children. Trupanion, a pet insurance company, has experienced wild revenue growth but struggles with increasing costs and negative margins. The company's balance sheet is not heavily burdened with liabilities, but profitability hinges on stabilizing operating expenses and addressing veterinary price hikes. Read the full article on Seeking Alpha
Article d’analyse Dec 18

A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb

Trupanion, Inc. ( NASDAQ:TRUP ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...
Article d’analyse Apr 18

What You Can Learn From Trupanion, Inc.'s (NASDAQ:TRUP) P/SAfter Its 35% Share Price Crash

The Trupanion, Inc. ( NASDAQ:TRUP ) share price has fared very poorly over the last month, falling by a substantial...

Rendement pour les actionnaires

TRUPUS InsuranceUS Marché
7D-12.6%-0.1%1.1%
1Y-50.8%-10.0%26.7%

Rendement vs Industrie: TRUP a sous-performé le secteur US Insurance qui a rapporté -10 % au cours de l'année écoulée.

Rendement vs marché: TRUP a sous-performé le marché US qui a rapporté 26.7 % au cours de l'année écoulée.

Volatilité des prix

Is TRUP's price volatile compared to industry and market?
TRUP volatility
TRUP Average Weekly Movement6.9%
Insurance Industry Average Movement4.3%
Market Average Movement7.2%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.1%

Cours de l'action stable: TRUP n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.

Volatilité au fil du temps: La volatilité hebdomadaire de TRUP ( 7% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
20061,121Margi Toothwww.trupanion.com

Trupanion Inc. et ses filiales proposent des assurances médicales pour chiens et chats sur la base d'abonnements aux États-Unis, au Canada, en Europe continentale et en Australie. L'entreprise exerce ses activités dans deux secteurs : les abonnements et les autres activités. Elle s'adresse aux propriétaires d'animaux de compagnie et aux vétérinaires.

Trupanion, Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Trupanion se comparent-ils à sa capitalisation boursière ?
TRUP statistiques fondamentales
Capitalisation boursièreUS$985.39m
Bénéfices(TTM)US$25.80m
Recettes(TTM)US$1.48b
37.8x
Ratio P/E
0.7x
Ratio P/S

Le site TRUP est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
TRUP compte de résultat (TTM)
RecettesUS$1.48b
Coût des recettesUS$1.15b
Marge bruteUS$330.92m
Autres dépensesUS$305.12m
Les revenusUS$25.80m

Derniers bénéfices déclarés

Mar 31, 2026

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)0.59
Marge brute22.34%
Marge bénéficiaire nette1.74%
Ratio dettes/capitaux propres27.7%

Quelles ont été les performances à long terme de TRUP?

Voir les performances historiques et les comparaisons

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/14 10:09
Cours de l'action en fin de journée2026/05/14 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Trupanion, Inc. est couverte par 16 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Christopher MerwinBarclays
Joshua ShankerBofA Global Research
Ryan TunisCantor Fitzgerald & Co.